Page last updated: 2024-08-26

lopinavir and Anemia

lopinavir has been researched along with Anemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cemillán-Fernández, CA; Domingo-García, J; Fouz-Ruiz, D; Gómez-Enjuto, S; Hernando-Requejo, V; Lapeña-Motilva, J; Ogando-Durán, G; Rodríguez-García, E1
Pérez Valero, I1

Reviews

1 review(s) available for lopinavir and Anemia

ArticleYear
[Prognostic factors of virological response in patients treated with lopinavir/ritonavir monotherapy].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 16

    Topics: Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Combinations; Hemoglobins; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Multicenter Studies as Topic; Patient Compliance; Pilot Projects; Prospective Studies; Pyrimidinones; Randomized Controlled Trials as Topic; Risk Factors; Ritonavir; Treatment Outcome; Viral Load

2008

Other Studies

1 other study(ies) available for lopinavir and Anemia

ArticleYear
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
    Seizure, 2020, Volume: 80

    Topics: Aged; Anemia; Anticoagulants; Anticonvulsants; Antiviral Agents; Betacoronavirus; Calcium Channel Blockers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Lymphopenia; Male; Pandemics; Pneumonia, Viral; Posterior Leukoencephalopathy Syndrome; Ritonavir; SARS-CoV-2; Status Epilepticus; Verapamil

2020